Kurtz, S. E., Eide, C. A., Kaempf, A., Mori, M., Tognon, C. E., Borate, U., . . . Tyner, J. W. (2018). Dual inhibition of JAK1/2 kinases and BCL2: A promising therapeutic strategy for acute myeloid leukemia. Leukemia.
Citação norma ChicagoKurtz, Stephen E., Christopher A. Eide, Andy Kaempf, Motomi Mori, Cristina E. Tognon, Uma Borate, Brian J. Druker, and Jeffrey W. Tyner. "Dual Inhibition of JAK1/2 Kinases and BCL2: A Promising Therapeutic Strategy for Acute Myeloid Leukemia." Leukemia 2018.
Citação norma MLAKurtz, Stephen E., et al. "Dual Inhibition of JAK1/2 Kinases and BCL2: A Promising Therapeutic Strategy for Acute Myeloid Leukemia." Leukemia 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.